AEON Biopharma, Inc. (New York Stock Exchange Arca:AEON)
| Market Cap | $6.14M-85.0% |
| Revenue (ttm) | $0 |
| Net Income | -$47.62M-1587233.3% |
| EPS | -$3.36-166.6% |
| Shares Out | 49.88M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,027,971 |
| Open | $0.13 |
| Previous Close | $0.13 |
| Day's Range | $0.12 - $0.13 |
| 52-Week Range | $0.11 - $1.45 |
| Beta | 0.69 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Mar 29, 2027 |
About AEON
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating AEON in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 29, 2027Earnings report
$AEON stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in AEON holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AEON's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AEON Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AEON patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AEON from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AEON
| VXFVanguard Extended Market ETF | $24.80K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from AEON’s recent data — informational, not investment advice
